Abstract

http://ssrn.com/abstract=1891992
 


 



A Prescription for Change: Citizens United’s Implications for Regulation of Off-Label Promotion of Prescription Pharmaceuticals


Kristie Anne LaSalle


affiliation not provided to SSRN

June 1, 2011

Journal of Law & Policy, Vol. 19, p. 867, 2011

Abstract:     
This Note examines the complex regulatory structure that controls off-label promotion of prescription pharmaceuticals. Using the recent case of United States v. Caronia as an example of the unconstitutional shortcomings of this regulatory scheme, the Note analogizes the FDA's obstruse regulatory scheme to the corporate campaign contributions limitations struck down in Citizens United v. FEC, and argues that the same logic applied in Citizens United should be applied to the regulation of truthful speech regarding prescription pharmaceuticals.

Number of Pages in PDF File: 46

Keywords: pharmaceuticals, Citizens United v. FEC, United States v. Caronia, first amendment

Accepted Paper Series


Download This Paper

Date posted: July 22, 2011  

Suggested Citation

LaSalle, Kristie Anne, A Prescription for Change: Citizens United’s Implications for Regulation of Off-Label Promotion of Prescription Pharmaceuticals (June 1, 2011). Journal of Law & Policy, Vol. 19, p. 867, 2011. Available at SSRN: http://ssrn.com/abstract=1891992

Contact Information

Kristie Anne LaSalle (Contact Author)
affiliation not provided to SSRN ( email )
Feedback to SSRN


Paper statistics
Abstract Views: 256
Downloads: 35

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo6 in 0.297 seconds